Compare FTAI Aviation Ltd (FTAI) vs Illumina, Inc. (ILMN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FTAI Aviation Ltd vs Illumina, Inc. — how do they compare? FTAI Aviation Ltd trades at $169.97 (market cap $17.57B), while Illumina, Inc. trades at $278.17 (market cap $39.95B). The key difference: Illumina, Inc. is far larger — about 2.3× FTAI Aviation Ltd's market cap, and FTAI Aviation Ltd pays a 1.17% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold FTAI Aviation Ltd for 23 Days and Illumina, Inc. for 83 Days on average.
| FTAI | ILMN | |
|---|---|---|
Market Cap | $17.57B | $39.95B |
Volume | 1,905,014 | 3,169,503 |
Sector | Industrials | Health |
52-Week High | $310.04 | $293.69 |
52-Week Low | $152.80 | $91.00 |
Typical Hold Time | 23 Days | 83 Days |
Enterprise Value | $20.69B | $41.31B |
Dividend Yield | 1.17% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FTAI Aviation trades at $171.06, down 2.16% on the day amid a bearish technical signal. The stock has missed earnings estimates for three consecutive quarters, though revenue growth remains robust, rising to $3.1B in 2026. Recent developments include a $500M share repurchase program and a strategic acquisition of 27 Boeing 737-700 aircraft, signaling management's confidence and expansion efforts.
The outlook is mixed: strong analyst consensus (100% buy ratings) and a high price target of $321.25 suggest significant upside, but recent earnings misses, negative operating cash flow, and a high P/E of 37.35 pose risks. Investors should weigh growth initiatives against execution challenges and valuation concerns.
Illumina (ILMN) trades at $264.40, down 1.25% on the day but remains near its 52-week high of $278.99, reflecting strong momentum with a 94.9% YTD gain. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Fundamentals show a significant turnaround, with net income reaching $850 million in 2025 after prior losses, supported by robust gross margins of 66.38%. Technical indicators are bullish overall, with key support at $257 and resistance at $268.
The outlook for ILMN is positive, driven by earnings momentum, inclusion in the S&P 500, and strategic AI initiatives in genomics. However, risks include high valuation multiples, such as a P/E of 49.36, and potential margin pressure from cost volatility. Analyst consensus is bullish with a 54% buy rating, though the consensus price target of $241 suggests limited near-term upside from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About FTAI Aviation Ltd
FTAI Aviation owns and maintains a fleet of commercial aircraft and engines. It focuses on the specialized maintenance of the CFM56 engine, helping airlines reduce costs through efficient asset management.
Read more on FTAI →About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →
